For the quarter ending 2026-03-31, AVTX has $99,885K in assets. $31,565K in debts. $24,988K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 24,988 | 15,858 | 26,963 | 42,290 |
| Short-term investments | 57,005 | 82,478 | 84,654 | 70,972 |
| Prepaid expenses and other current assets | 6,685 | 6,913 | 2,139 | 1,903 |
| Restricted cash, current portion | 147 | 37 | 90 | 20 |
| Total current assets | 88,825 | 105,286 | 113,846 | 115,185 |
| Property and equipment, net | 375 | 460 | 542 | 686 |
| Goodwill | 10,502 | 10,502 | 10,502 | 10,502 |
| Restricted cash, net of current portion | 183 | 210 | 210 | 210 |
| Total assets | 99,885 | 116,458 | 125,100 | 126,583 |
| Derivative liability, current | - | 0 | 0 | 370 |
| Accounts payable | 356 | 137 | 474 | 2,366 |
| Accrued expenses and other current liabilities | 11,243 | 12,803 | 7,498 | 6,523 |
| Total current liabilities | 11,599 | 12,940 | 7,972 | 9,259 |
| Royalty obligation | 2,000 | 2,000 | 2,000 | 2,000 |
| Deferred tax liability, net | 446 | 434 | 304 | 293 |
| Derivative liability, non-current | 17,520 | 18,000 | 23,160 | 10,260 |
| Other long-term liabilities | 0 | 35 | 117 | 197 |
| Total liabilities | 31,565 | 33,409 | 33,553 | 22,009 |
| Temporary equity, values issued-Series DPreferred Stock | 0 | 0 | 0 | 0 |
| Temporary equity, values issued-Series EPreferred Stock | 0 | 0 | 0 | 0 |
| Common stock0.001 par value 200,000,000 shares authorized at march31, 2026 and december31, 2025 24,637,807 and 18,512,757 shares issued and outstanding at march31, 2026 and december31, 2025, respectively | 25 | 18 | 18 | 11 |
| Additional paid-in capital | 536,453 | 531,485 | 526,290 | 508,774 |
| Accumulated other comprehensive (loss) income | -6 | 68 | 41 | -34 |
| Accumulated deficit | -468,152 | -448,522 | -434,802 | -404,177 |
| Temporary equity, values issued | - | - | - | 0 |
| Total stockholders equity | 68,320 | 83,049 | 91,547 | 104,574 |
| Total liabilities, mezzanine equity and stockholders equity | 99,885 | 116,458 | 125,100 | 126,583 |
Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. (AVTX)